COMPANY PROFILE · /amboss
A

AMBOSS

AMBOSS is a digital medical knowledge platform providing clinical decision support and medical education tools for medical students and healthcare professionals. The platform combines peer-reviewed medical content with AI-powered features including semantic search, study recommendations, and clinical intelligence (LiSA) ranked #1 in Stanford-Harvard NOHARM safety studies.

amboss.com ↗· Berlin, Germany· founded 2012reported
Fresh · 5d ago
Latest valuation
$undisclosed (likely $1B+)
Annual Recurring Revenue
~$80-100M estimated
Headcount
500+
Funding total
$298M
OVERVIEW

<cite index="41-8,45-1">Raised €240 million ($260M) in March 2025 led by Kirkbi, M&G Investments, and Lightrock</cite>. <cite index="49-10,49-12">Over 1 million users in 180+ countries; majority of US medical students use AMBOSS for exam prep</cite>. <cite index="49-18,49-17">In 2024 acquired nursing education platform Novaheal and NEJM Knowledge+, signaling M&A strategy in medical education</cite>.

Status
active
Tier
master-list
Profitability
Approaching profitability
Pricing
freemium, enterprise, B2B institutional
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0

No products catalogued yet. Press Refresh above to ask the research agent.

TEAM · 0 key people

No people linked.

SOURCES · 0 cited

No citations stored yet. Run the research agent to attach per-claim sources.